デガレリクスの世界市場 2020年

• 英文タイトル：Global Degarelix Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201114155 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、デガレリクスの世界市場を調査対象にし、デガレリクスの市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（120mg/バイアル、80mg/バイアル）、用途別分析（病院、ドラッグストア）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Ferring ・企業別売上、市場シェア ・デガレリクスの地域別市場分析 ・デガレリクスの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・デガレリクスのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・デガレリクスのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・デガレリクスの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・デガレリクスの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・デガレリクスの種類別市場規模2015-2020：120mg/バイアル、80mg/バイアル ・デガレリクスの用途別市場規模2015-2020：病院、ドラッグストア ・デガレリクスの世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The global Degarelix market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Degarelix market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Degarelix market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Degarelix market has been segmented into:
120 mg per vial
80 mg per vial

By Application, Degarelix has been segmented into:
Hospital
Drug store

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Degarelix market presented in the report. This section sheds light on the sales growth of different regional and country-level Degarelix markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Degarelix market.

The report offers in-depth assessment of the growth and other aspects of the Degarelix market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Degarelix Market Share Analysis
Degarelix competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Degarelix sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Degarelix sales, revenue and market share for each player covered in this report.

The major players covered in Degarelix are:
Ferring

レポート目次

---

1 Degarelix Market Overview
1.1 Product Overview and Scope of Degarelix
1.2 Classification of Degarelix by Type
1.2.1 Global Degarelix Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Degarelix Revenue Market Share by Type in 2019
1.2.3 120 mg per vial
1.2.4 80 mg per vial
1.3 Global Degarelix Market by Application
1.3.1 Overview: Global Degarelix Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Drug store
1.4 Global Degarelix Market by Regions
1.4.1 Global Degarelix Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Degarelix (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Degarelix Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Degarelix Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Degarelix Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Degarelix Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Degarelix Status and Prospect (2015-2025)
2 Company Profiles
2.1 Ferring
2.1.1 Ferring Details
2.1.2 Ferring Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Ferring SWOT Analysis
2.1.4 Ferring Product and Services
2.1.5 Ferring Degarelix Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Degarelix Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Degarelix Players Market Share
3.2.2 Top 10 Degarelix Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Degarelix Revenue and Market Share by Regions
4.2 North America Degarelix Revenue and Growth Rate (2015-2020)
4.3 Europe Degarelix Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Degarelix Revenue and Growth Rate (2015-2020)
4.5 South America Degarelix Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Degarelix Revenue and Growth Rate (2015-2020)
5 North America Degarelix Revenue by Countries
5.1 North America Degarelix Revenue by Countries (2015-2020)
5.2 USA Degarelix Revenue and Growth Rate (2015-2020)
5.3 Canada Degarelix Revenue and Growth Rate (2015-2020)
5.4 Mexico Degarelix Revenue and Growth Rate (2015-2020)
6 Europe Degarelix Revenue by Countries
6.1 Europe Degarelix Revenue by Countries (2015-2020)
6.2 Germany Degarelix Revenue and Growth Rate (2015-2020)
6.3 UK Degarelix Revenue and Growth Rate (2015-2020)
6.4 France Degarelix Revenue and Growth Rate (2015-2020)
6.5 Russia Degarelix Revenue and Growth Rate (2015-2020)
6.6 Italy Degarelix Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Degarelix Revenue by Countries
7.1 Asia-Pacific Degarelix Revenue by Countries (2015-2020)
7.2 China Degarelix Revenue and Growth Rate (2015-2020)
7.3 Japan Degarelix Revenue and Growth Rate (2015-2020)
7.4 Korea Degarelix Revenue and Growth Rate (2015-2020)
7.5 India Degarelix Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Degarelix Revenue and Growth Rate (2015-2020)
8 South America Degarelix Revenue by Countries
8.1 South America Degarelix Revenue by Countries (2015-2020)
8.2 Brazil Degarelix Revenue and Growth Rate (2015-2020)
8.3 Argentina Degarelix Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Degarelix by Countries
9.1 Middle East & Africa Degarelix Revenue by Countries (2015-2020)
9.2 Saudi Arabia Degarelix Revenue and Growth Rate (2015-2020)
9.3 UAE Degarelix Revenue and Growth Rate (2015-2020)
9.4 Egypt Degarelix Revenue and Growth Rate (2015-2020)
9.5 South Africa Degarelix Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Degarelix Revenue and Market Share by Type (2015-2020)
10.2 Global Degarelix Market Forecast by Type (2019-2024)
10.3 120 mg per vial Revenue Growth Rate (2015-2025)
10.4 80 mg per vial Revenue Growth Rate (2015-2025)
11 Global Degarelix Market Segment by Application
11.1 Global Degarelix Revenue Market Share by Application (2015-2020)
11.2 Degarelix Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Drug store Revenue Growth (2015-2020)
12 Global Degarelix Market Size Forecast (2021-2025)
12.1 Global Degarelix Market Size Forecast (2021-2025)
12.2 Global Degarelix Market Forecast by Regions (2021-2025)
12.3 North America Degarelix Revenue Market Forecast (2021-2025)
12.4 Europe Degarelix Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Degarelix Revenue Market Forecast (2021-2025)
12.6 South America Degarelix Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Degarelix Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Degarelix Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Degarelix by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Degarelix Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Degarelix Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Ferring Corporate Information, Location and Competitors
Table 6. Ferring Degarelix Major Business
Table 7. Ferring Degarelix Total Revenue (USD Million) (2017-2018)
Table 8. Ferring SWOT Analysis
Table 9. Ferring Degarelix Product and Solutions
Table 10. Ferring Degarelix Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Global Degarelix Revenue (Million USD) by Players (2015-2020)
Table 12. Global Degarelix Revenue Share by Players (2015-2020)
Table 13. Global Degarelix Revenue (Million USD) by Regions (2015-2020)
Table 14. Global Degarelix Revenue Market Share by Regions (2015-2020)
Table 15. North America Degarelix Revenue by Countries (2015-2020)
Table 16. North America Degarelix Revenue Market Share by Countries (2015-2020)
Table 17. Europe Degarelix Revenue (Million USD) by Countries (2015-2020)
Table 18. Asia-Pacific Degarelix Revenue (Million USD) by Countries (2015-2020)
Table 19. South America Degarelix Revenue by Countries (2015-2020)
Table 20. South America Degarelix Revenue Market Share by Countries (2015-2020)
Table 21. Middle East and Africa Degarelix Revenue (Million USD) by Countries (2015-2020)
Table 22. Middle East and Africa Degarelix Revenue Market Share by Countries (2015-2020)
Table 23. Global Degarelix Revenue (Million USD) by Type (2015-2020)
Table 24. Global Degarelix Revenue Share by Type (2015-2020)
Table 25. Global Degarelix Revenue Forecast by Type (2021-2025)
Table 26. Global Degarelix Revenue by Application (2015-2020)
Table 27. Global Degarelix Revenue Share by Application (2015-2020)
Table 28. Global Degarelix Revenue Forecast by Application (2021-2025)
Table 29. Global Degarelix Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Degarelix Picture
Figure 2. Global Degarelix Revenue Market Share by Type in 2019
Figure 3. 120 mg per vial Picture
Figure 4. 80 mg per vial Picture
Figure 5. Degarelix Revenue Market Share by Application in 2019
Figure 6. Hospital Picture
Figure 7. Drug store Picture
Figure 8. Global Degarelix Revenue (USD Million) and Growth Rate (2015-2025)
Figure 9. North America Degarelix Revenue (Million USD) and Growth Rate (2015-2025)
Figure 10. Europe Degarelix Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Asia-Pacific Degarelix Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. South America Degarelix Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Middle East and Africa Degarelix Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Global Degarelix Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Degarelix Revenue Share by Players in 2019
Figure 16. Global Top 5 Players Degarelix Revenue Market Share in 2019
Figure 17. Global Top 10 Players Degarelix Revenue Market Share in 2019
Figure 18. Key Players Market Share Trend
Figure 19. Global Degarelix Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 20. Global Degarelix Revenue Market Share by Regions (2015-2020)
Figure 21. Global Degarelix Revenue Market Share by Regions in 2018
Figure 22. North America Degarelix Revenue and Growth Rate (2015-2020)
Figure 23. Europe Degarelix Revenue and Growth Rate (2015-2020)
Figure 24. Asia-Pacific Degarelix Revenue and Growth Rate (2015-2020)
Figure 25. South America Degarelix Revenue and Growth Rate (2015-2020)
Figure 26. Middle East and Africa Degarelix Revenue and Growth Rate (2015-2020)
Figure 27. North America Degarelix Revenue Market Share by Countries (2015-2020)
Figure 28. North America Degarelix Revenue Market Share by Countries in 2019
Figure 29. USA Degarelix Revenue and Growth Rate (2015-2020)
Figure 30. Canada Degarelix Revenue and Growth Rate (2015-2020)
Figure 31. Mexico Degarelix Revenue and Growth Rate (2015-2020)
Figure 32. Europe Degarelix Revenue Market Share by Countries (2015-2020)
Figure 33. Europe Degarelix Revenue Market Share by Countries in 2019
Figure 34. Germany Degarelix Revenue and Growth Rate (2015-2020)
Figure 35. UK Degarelix Revenue and Growth Rate (2015-2020)
Figure 36. France Degarelix Revenue and Growth Rate (2015-2020)
Figure 37. Russia Degarelix Revenue and Growth Rate (2015-2020)
Figure 38. Italy Degarelix Revenue and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Degarelix Revenue Market Share by Countries (2015-2020)
Figure 40. Asia-Pacific Degarelix Revenue Market Share by Countries in 2019
Figure 41. China Degarelix Revenue and Growth Rate (2015-2020)
Figure 42. Japan Degarelix Revenue and Growth Rate (2015-2020)
Figure 43. Korea Degarelix Revenue and Growth Rate (2015-2020)
Figure 44. India Degarelix Revenue and Growth Rate (2015-2020)
Figure 45. Southeast Asia Degarelix Revenue and Growth Rate (2015-2020)
Figure 46. South America Degarelix Revenue Market Share by Countries (2015-2020)
Figure 47. South America Degarelix Revenue Market Share by Countries in 2019
Figure 48. Brazil Degarelix Revenue and Growth Rate (2015-2020)
Figure 49. Argentina Degarelix Revenue and Growth Rate (2015-2020)
Figure 50. Middle East and Africa Degarelix Revenue Market Share by Countries (2015-2020)
Figure 51. Middle East and Africa Degarelix Revenue Market Share by Countries in 2019
Figure 52. Saudi Arabia Degarelix Revenue and Growth Rate (2015-2020)
Figure 53. UAE Degarelix Revenue and Growth Rate (2015-2020)
Figure 54. Egypt Degarelix Revenue and Growth Rate (2015-2020)
Figure 55. South Africa Degarelix Revenue and Growth Rate (2015-2020)
Figure 56. Global Degarelix Revenue Share by Type (2015-2020)
Figure 57. Global Degarelix Revenue Share by Type in 2019
Figure 58. Global Degarelix Market Share Forecast by Type (2021-2025)
Figure 59. Global 120 mg per vial Revenue Growth Rate (2015-2020)
Figure 60. Global 80 mg per vial Revenue Growth Rate (2015-2020)
Figure 61. Global Degarelix Revenue Share by Application (2015-2020)
Figure 62. Global Degarelix Revenue Share by Application in 2019
Figure 63. Global Degarelix Market Share Forecast by Application (2021-2025)
Figure 64. Global Hospital Revenue Growth Rate (2015-2020)
Figure 65. Global Drug store Revenue Growth Rate (2015-2020)
Figure 66. Global Degarelix Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 67. Global Degarelix Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 68. Global Degarelix Revenue Market Share Forecast by Regions (2021-2025)
Figure 69. North America Degarelix Revenue Market Forecast (2021-2025)
Figure 70. Europe Degarelix Revenue Market Forecast (2021-2025)
Figure 71. Asia-Pacific Degarelix Revenue Market Forecast (2021-2025)
Figure 72. South America Degarelix Revenue Market Forecast (2021-2025)
Figure 73. Middle East and Africa Degarelix Revenue Market Forecast (2021-2025)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel

---